Be part of an ongoing research effort to protect the public against COVID-19
If you’ve completed your primary series shots against COVID-19, you may be able to join a study of an investigational COVID-19 vaccine. The study drug, VXA-CoV2-3.1, is a tablet designed to work as a booster or as a standalone vaccine.
You may be able to join the VXA-COV-202 Study if you:
- Are at 18 years of age or older
- Have had 2 or more mRNA shots against COVID-19, such as Moderna
or Pfizer
- Had your last COVID-19 shot at least 6 months before you take the study drug
- Be in overall stable health
There are other requirements, which the study team will go over with you. Reimbursement for study-related expenses will be provided.